Real-world Diagnosis of Chronic Migraine in Patients with Cervical Dystonia Analyzed by Botulinum Neurotoxin Treatment Exposure: An Epidemiologic Perspective (P9-2.012)
Describe the real-world diagnosis, demographics, and clinical characteristics of chronic migraine (CM) in cervical dystonia (CD) patients stratified by botulinum neurotoxin (BoNT) treatment.
Authors
- Kimberly Becker Ifantides (ORCID: https://orcid.org/0009-0006-5303-7992)
- Ramon L. Rodriguez (ORCID: https://orcid.org/0009-0008-8005-9200)
- Harini Sarva (ORCID: https://orcid.org/0000-0002-0320-2893)
- Grace Forde
- Ahunna Ukah
- Marjan Sadeghi (ORCID: https://orcid.org/0000-0003-1609-1616)
- Christopher Rhyne (ORCID: https://orcid.org/0000-0002-4540-4485)
- Emma Yue
- Susan W. Broner
Institutions
- Cornell University (US)
- AbbVie (United States) (US)
- Neuroscience Institute (IT)
- Weill Cornell Medicine (US)
- AbbVie (Japan)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210731
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00